Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Amryt Pharma Plc LSE:AMYT London Ordinary Share GB00BKLTQ412 ORD 6P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 143.00 151.00 170.00 - 0.00 01:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 49.2 -56.5 -72.8 - 457

Amryt Pharma Share Discussion Threads

Showing 7276 to 7296 of 7300 messages
Chat Pages: 292  291  290  289  288  287  286  285  284  283  282  281  Older
DateSubjectAuthorDiscuss
23/6/2022
20:41
Thanks. A pity.
gnnmartin
23/6/2022
15:08
The CVR was awarded upon CHMP opinion not EC approval. But..it's only $5M in total.
onceaday
23/6/2022
14:58
European Commission Approves Filsuvez® for the treatment of Dystrophic and Junctional EB. Does this mean a payment on the contingent rights? Or is it too late for that?
gnnmartin
22/6/2022
16:19
Where's AP103? https://finance.yahoo.com/news/krystal-biotech-submits-biologics-license-110000212.html
chica1
05/6/2022
19:15
Good not could !
richpassi
05/6/2022
19:14
How could I say anything else ! Hope you could Pap ;)
richpassi
05/6/2022
13:06
👍 richpassi 🤣🤣🤣🤣
papillon
05/6/2022
10:41
I wouldn't ;) lol
richpassi
04/6/2022
15:29
Does Mrs Claris Bemedicta advise buying Amryt? 😄😄😄
onceaday
04/6/2022
12:07
Just catching up on this; so this was from the announcement:The total amount payable to CVR Holders will be approximately USD$5.7million. Each CVR Holder will be issued with one loan note of USD$0.0995 for each CVR they hold (each a "Loan Note"). The certificates for the Loan Notes will be held by the Company's Registrar, Link Group ("Link"), in electronic form on behalf of each CVR Holder. So I assume this means that we will receive 9.95 USD cents for each CVR. This will actually arrive on the 14th September. Is this other peoples understanding? https://otp.tools.investis.com/clients/uk/amryt_pharmaceuticals_dac1/usn/usnews-story.aspx?cid=1375&newsid=83319
exfm
19/5/2022
18:59
Oh great. That's worthless.in that case.
onceaday
19/5/2022
17:38
Revenue CVR is also timebound:- "A contingent entitlement of up to a maximum amount of $35,000,000 on Amryt achieving a 12-Month Trailing Net Product Revenue in excess of $75,000,000 from sales of AP101 prior to 30 June 2024"
40plus
18/5/2022
16:53
There are three CVRs. EMA, FDA and $75M revenue.The first two are time-bound but I think revenue is not. Happy to be corrected.
onceaday
18/5/2022
10:42
Well at least the $ is strong (and should be) when the time comes. I'm surprised we're getting anything,I thought the CVR's were for FDA approval not EMA. I can't see the FDA changing their decision because I think there's been a fudge at the EMA as Episalvan already had Partial Thickness Wounds approval (which the FDA already rejected in 2016)
chica1
17/5/2022
16:39
Ler's hope your broker will accept a dollar denominated cheque! :-)
onceaday
17/5/2022
15:20
Great,we'll be able to buy a few rounds to celebrate so on 22nd September!!
punter6
08/5/2022
11:12
Near end of Q1 2022 Conf Call on 4th May, Rory Nealon advises EMA CVR to payout at approx 9.9 US Cents per CVR payable in around 4 Months time.
40plus
04/5/2022
13:05
An even bigger loss than the same quarter last year. Cash pile shrinking... Will Amryt ever be profitable?
onceaday
26/4/2022
13:48
Onwards & upwards!
bazworth
26/4/2022
12:40
Are we expecting good things from the Q4 results next Wednesday?!
punter6
22/4/2022
16:49
If you are interested in the format of the post-CRL meeting then here are the guidance notes.. https://www.fda.gov › mediaPDF Post-Complete Response Letter Meetings Between FDA and ANDA Applicants ...
onceaday
Chat Pages: 292  291  290  289  288  287  286  285  284  283  282  281  Older
ADVFN Advertorial
Your Recent History
LSE
AMYT
Amryt Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220701 10:46:21